References
- Anderson G W, Even C, Rowland R R R, Palmer G A, Harty J T, Plagemann P G W. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J Neurovirol 1995a; 1: 244–252
- Anderson G W, Palmer G A, Rowland R R R, Even C, Plagemann P G W. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in utero infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus. J Virol 1995b; 69: 308–319
- Anderson G W, Palmer G A, Rowland R R R, Even C, Plagemann P G W. Lactate dehydrogenase-elevating virus entry into central nervous system, and replication in anterior horn neurons. J Gen Virol 1995c; 76: 581–592
- Brinton M A, Cavin E I, Weibel J. Detection of viral-specific nucleic acid and intracellular virions in ventral horn neurons of lactate dehydrogenase-elevating virus infected C58 mice. Microb Pathogen 1986; 1: 595–602
- Brinton-Damell M, Plagemann P G W. Structural and chemical-physical characteristics of lactate dehydrogenase-elevating virus and its RNA. J Virol 1975; 16: 420–433
- Cafruny W A, Chan S P K, Harty J T, Yousefi S, Kowalchyk K, McDonald D, Foreman B, Budweg G, Plagemann P G W. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus. Virus Res 1986; 5: 357–375
- Cafruny W A, Haven T R, Lawson S R, Wong G H W, Rowland R R R. Inhibition of virus-induced age-dependent poliomyelitis by interferon-γ. Antiviral Res 1997; 36: 1–9
- Chen Z, Plagemann P G W. Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT.-PCR assays and its removal from the tumor cells. J Virol Meth 1997; 65: 227–236
- Chen Z, Rowland R R R, Anderson G W, Plagemann P G W. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogeni-city and ability to establish a persistent infection. J Virol 1997; 71: 2913–2920
- Chen Z, Li K, Rowland R R R, Anderson G W, Plagemann P G W. Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired ability for high viremic persistent infection. J Neurovirol 1998, In press
- Coutelier J P, van Snick J. Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies. J Gen Virol 1988; 69: 2097–2100
- Faaberg K S, Plagemann P G W. The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography. Virology 1995; 212: 512–525
- Faaberg K S, Even C, Palmer G A, Plagemann P G W. Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity. J Virol 1995a; 69: 613–617
- Faaberg K S, Palmer G A, Even C, Anderson G W, Plagemann P G W. Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase-elevating virus that differ in neuropathogenicity. Virus Res 1995b; 39: 331–340
- Harty J T, Plagemann P G W. Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection. J Virol 1988; 62: 3210–3216
- Harty J T, Plagemann P G W. Monoclonal antibody protection from age-dependent poliomyelitis: Implications regarding the pathogenesis of lactate dehydrogenase-elevating virus. J Virol 1990; 64: 6257–6262
- Harty J T, Chan S P K, Contag C H, Plagemann P G W. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication. J Neuroimmunol 1987; 15: 195–206
- Li K, Chen Z, Plagemann P G W. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. Virology 1998; 242: 239–245
- Murphy W H, Nawrocki J F, Pease L R. Age-dependent paralytic viral infection in C58 mice: Possible implication in human neurologic disease. Prog Brain Res 1983; 59: 291–303
- Murphy W H, Mazur J J, Fulton S A. Animal model for motor neuron disease. Clinical Neuroimmunology, W MH Behan, P O Behan, J A Aarli. Blackwell Scientific Publications, OxfordEngland 1987; 135–155
- Onyekaba C O, Harty J T, Plagemann P G W. Extensive cytocidal replication of lactate dehydrogenase-elevating virus in cultured peritoneal macrophages from 1- and 2-week-old mice. Virus Res 1989; 14: 327–338
- Plagemann P G W. Lactate dehydrogenase-elevating virus and related viruses. Virology3rd Edition, B N Fields, D M Knipe, P M Howley. Raven Press, New York 1996; 1105–1120
- Plagemann P G W, Moennig V. Lactate dehydrogenase-elevating virus, equine arteritis virus and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv Virus Res 1992; 41: 99–192
- Plagemann P G W, Gregory K F, Swim H E, Chan K K W. Plasma lactic dehydrogenase elevating agent of mice. Distribution in tissues and effect our lactate dehydrogenase isozyme patterns. Can J Microbiol 1963; 9: 75–86
- Plagemann P G W, Harty J T, Even C. Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies. Arch Virol 1992; 123: 89–100
- Plagemann P G W, Rowland R R R, Even C, Faaberg K S. Lactate dehydrogenase-elevating virus-an ideal persistent virus?. Semin Immunopathol 1995; 17: 167–186
- Rowson K E K, Mahy B W J. Lactic dehydrogenase virus. Virol Monog 13, Springer Verlag, Wien 1975
- Stueckemann J A, Ritzi D M, Holth M, Smith M S, Swart W J, Cafruny W A, Plagemann P G W. Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication. J Gen Virol 1982; 59: 245–262